Skip to main content
. 2009 Mar;32(3):439–444. doi: 10.2337/dc08-1195

Table 2.

Characteristics of individuals with incident i-IFG, i-IGT, IFG/IGT, or NGT (5-year follow-up)

NGT → NGT NGT → i-IFG NGT → i-IGT NGT → IFG/IGT P < 0.05*
n 2,842 83 192 28
BMI (kg/m2) 25.6 (25.5–25.8) 28.2 (27.4–29.1) 27.4 (26.8–27.9) 29.1 (27.6–30.6) a, b, c
Waist circumference (cm) 86.5 (86.1–86.9) 95.9 (93.4–98.5) 91.8 (90.1–93.5) 98.5 (94.1–102.9) a, b, c, f
Physical activity (min/week) 301 (296–307) 299 (265–333) 256 (233–279) 309 (250–368) b
Dietary quality score (points) 4.60 (4.54–4.65) 4.37 (4.06–4.69) 4.25 (4.04–4.46) 4.46 (3.89–5.03) b
Fasting plasma glucose (mmol/l) 5.2 (5.2–5.2) 6.4 (6.3–6.4) 5.4 (5.1–5.4) 6.4 (6.2–6.6) a, b, c, d, f
2-h plasma glucose (mmol/l) 5.2 (5.2–5.3) 5.8 (5.6–6.0) 8.6 (8.5–8.8) 8.5 (8.1–8.9) a, b, c, d, e
Fasting serum insulin (pmol/l) 27 (20–39) 48 (34–67) 37 (25–54) 56 (37–91) a, b, c, d, f
2-h serum insulin (pmol/l) 139 (85–211) 202 (103–292) 365 (231–560) 361 (246–571) a, b, c, d, e
ISI 2.68 (2.19–3.43) 1.99 (1.69–2.54) 1.47 (1.27–1.67) 1.36 (1.20–1.58) a, b, c, d, e
HOMA-IS 1.11 (0.75–1.54) 0.51 (0.36–0.73) 0.79 (0.54–1.17) 0.45 (0.33–0.67) a, b, c, d, f
EPIR 746 (569–978) 639 (380–960) 670 (447–903) 586 (365–1,001) a, b, c, f
DI 2,084 (1,514–2,864) 1,325 (918–1,949) 1,047 (656–1,312) 815 (516–1,185) a, b, c, d, e

Data are unadjusted means and proportions (95% CI) unless otherwise indicated. n = 3,145.

*

P values are adjusted for age, sex, and risk/intervention group. P values for BMI were further adjusted for 5-year physical activity level. P values for ISI, HOMA-IS, EPIR, and DI were further adjusted for family history of diabetes as well as 5-year values of BMI, smoking, physical activity, and dietary quality. Wald test from linear models: a, i-IFG vs. NGT; b, i-IGT vs. NGT; c, IFG/IGT vs. NGT; d, i-IGT vs. i-IFG; e, IFG/IGT vs. i-IFG; f, IFG/IGT vs. i-IGT.

Unadjusted medians (interquartile range).